In a previous study, we found Serratia marcescens is a nosocomial pathogen capable of causing severe infections in debilitated patients. The monitoring of outbreaks caused by this organism requires reliable and discriminatory typing methods, and reference laboratories use the 0 antigen as the primary epidemiological marker (1, 10), often in conjunction with H serology. Unfortunately, 0 serotyping can be of limited use in some studies because of the high frequency of isolates agglutinated by 014 antiserum. It has been shown that putative microcapsular antigens may mask the lipopolysaccharide (LPS) 0 antigen in agglutination tests, probably giving rise to a number of falsepositive reactions with 014 antiserum (2). Confusion over the identification of 0 antigens in the established 0-serotype strains may further reduce the value of 0 serology (3).
Serratia marcescens is a nosocomial pathogen capable of causing severe infections in debilitated patients. The monitoring of outbreaks caused by this organism requires reliable and discriminatory typing methods, and reference laboratories use the 0 antigen as the primary epidemiological marker (1, 10), often in conjunction with H serology. Unfortunately, 0 serotyping can be of limited use in some studies because of the high frequency of isolates agglutinated by 014 antiserum. It has been shown that putative microcapsular antigens may mask the lipopolysaccharide (LPS) 0 antigen in agglutination tests, probably giving rise to a number of falsepositive reactions with 014 antiserum (2) . Confusion over the identification of 0 antigens in the established 0-serotype strains may further reduce the value of 0 serology (3) .
There is therefore a need to reassess the role of agglutination tests in identifying 0 antigens within the species and to establish an alternative and more accurate test method. We have prepared a set of absorbed antisera that have a high degree of LPS specificity within the serotypes strains, and using a simple dot enzyme immunoassay (dot EIA), we have determined the serotypes prevalent in a collection of clinical strains. We present here the results of this study and compare the technique with the traditional agglutination test.
MATERIALS AND METHODS
Strains. A total of 104 clinical strains from 40 medical centers in the United Kingdom and abroad were selected from cultures sent to our laboratory for epidemiological investigations between 1983 and 1987. Strains were originally identified as S. marcescens by the sending laboratory and were subsequently screened for failure to produce acid from lactose, rhamnose, raffinose, and arabinose. Atypical cultures were identified with the API 20E system. Strains were considered to be distinct on the basis of routine 0 serotyping and phage susceptibility. The 0-serotype strains 01 to 024 were as described previously (3) .
Electrophoresis. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was carried out by using standard methods (8, 12) , with 10% resolving gels. Separated components from sodium dodecyl sulfate-polyacrylamide gels were transferred to nitrocellulose as described previously (2) . LPS-containing extracts were prepared by the proteinase K digestion method (5) . Extracts from all 104 strains were silver stained, and the results were compared with the profiles of the serotype strains.
Antisera. Antisera towards the serotype strains 01 to 024 and experimental strains were prepared as described previously (10) . Absorption to remove heterologous antibodies was carried out as described by Gaston and Pitt (3) .
Serotyping. (i) Agglutination. Antigens were prepared from cultures grown overnight in 3 ml of tryptone soya broth. Cultures were heated for 1 h at 100°C, and antigen was collected by centrifugation (4,000 x g, 20 min) and suspended in 5 ml of phosphate-buffered saline, pH 7.4 . Tests were performed in microdilution trays as described previously (10) .
(ii) Dot EIA. Cell growth from cultures incubated overnight at 37°C in 3 ml of tryptone soya broth was collected by centrifugation (4,000 x g), suspended in 3 ml of saline, and heated for 1 h at 100°C. Approximately 5 to 10 ,t1 of heated antigen was applied to a nitrocellulose membrane (0.45-,um pore size; Gelman Sciences) and allowed to dry for 30 min at 37°C. Membranes were stored at room temperature prior to use. Incubations with antisera and detection of bound antibodies were carried out as described previously (3).
(iii) Absorbed antiserum scheme. The strains used to absorb 0 antisera 01 to 024 are given in Table 1 . Two novel 0 antigens were identified in preliminary studies on clinical isolates, and antisera towards their respective serotype strains, S3255 and S1254, were included in the study.
(iv) Identification of 0 antigen. Each strain was tested in dot EIA with unabsorbed and absorbed antisera 01 to 024 and the two additional antisera. All strong reactions with absorbed antisera were immunoblotted to determine whether they corresponded to an LPS-specific reaction. Each strain was also immunoblotted with unabsorbed 014 antiserum, regardless of dot EIA reactions. Strains that did not give a homologous reaction in immunoblotting were classed as false-positive.
RESULTS
Distribution of O antigens in clinical strains. Ninety-one (87.5%) strains had typical enterobacterial LPS profiles and were assigned to a specific O serotype. Twelve strains were classed as "rough or semirough" (R/SR), as they did not express high-molecular-weight LPS in silver-stained poly- acrylamide gels (Fig. 1) . One further strain, with a complete LPS profile, did not appear to belong to any of the recognized serotypes (O-NT).
The distribution of antigens is given in Table 2 . Twelve O antigens were found in the 91 typable strains, but only nine accounted for more than one strain. The LPS profiles of these serotypes are shown in Fig. 2 (Table 3) , and only 36 (34.6%) strains gave identical types in both test systems. Only 30 of the 66 strains agglutinated by 014 antiserum had an 012/014 0 antigen. Overall, the majority of strains belonging to 04, 06/07, 08, and S1254 were agglutinated by 014 antiserum. In immunoblotting, LPS extracts from the heterologous or false-positive strains showed a "smeared" reaction in the area of the blot that corresponded to the top quarter of the sodium dodecyl sulfate-polyacrylamide gel. A similar smeared reaction was given by the six strains agglutinated by 05 antiserum. None of the six strains possessed O antigens indistinguishable from 05 LPS. Three had R/SR LPS, and three had LPS antigens indistinguishable from S3255. Similarly, none of the four strains agglutinated by 03 had 02/03 0 antigen. Immunoblotting showed that they expressed 021 LPS, a serologically related antigen.
Pigmentation and LPS phenotype. Strains were examined for pigmentation after 6 days of incubation at room temperature (-22°C). Nineteen showed prodigiosin production; their O antigens are given in Table 4 . The majority of strains of three phenotypes, 06/07, 08, and S3255, were pigmented. In addition, three strains with R/SR LPS were pigmented. No strains belonging to any of the three most frequent O antigens expressed prodigiosin.
DISCUSSION
In members of the Enterobacteriaceae, the 0-side-chain polysaccharide component of LPS contains the serological determinant for the O antigen and is therefore the basis of O serology in most species. However, the clear implication of serological studies in our laboratory and chemical analyses by Wilkinson and colleagues is that O antigens of S. mar- (3) . The problems with the O scheme are compounded by the inclusion of two apparently rough strains, 011 and 013, in the serotyping set (3) . In light of these results, there is a need to redefine the O antigens represented by the typing scheme. Concomitantly, there is a need to reassess the serotyping methods applied to clinical strains. The dot EIA method presented here appears to be a significant improvement on the traditional agglutination method. O antigens are identified with greater accuracy, and the discriminatory power of serotyping is improved with the reduction of false-positive reactions with 014 antiserum. By using a recently described numerical index (D) of the discriminatory ability of typing schemes (7), serotyping by agglutination has a D value of 0.574. This is improved to 0.851 with dot EIA; i.e., 85.1% of pairs of unrelated strains can be separated into different serotypes.
The inclusion of antisera raised against S3255 and S1254 in the typing scheme improved the typability of O serology by 17.3%. These antisera would therefore be useful additions to the routine typing reagents of reference laboratories. However, as there is a strong case to be made that the O serology of this species should be reappraised, we do not propose that these novel serotypes be adopted as 025 and 026, respectively. In addition, it could be argued that the prevalence of S1254 antigen in clinical material highlights the unrepresentative nature of the current set of O-serotype strains. One solution to the problems we and others have found with the current O scheme would be to establish the distribution of O antigens in a large and representative collection of international strains. We would then have a more complete view of the O antigens relevant to clinical situations and would be better placed to propose an amended serotype scheme, based as far as possible on the original serotype designations. The association between O and H antigens should also be reassessed (4) .
The segregation of pigmented strains into biotypes and serotypes has been reported previously (4) . In our laboratory, this association has not been readily apparent because of the high proportion of pigmented 06 and 08 strains that have been misclassified as pigmented 014 strains. The three most frequent O antigens were associated with a nonpigmented phenotype. The frequency of these O antigens in clinical specimens could therefore be the major factor in the predominance of nonpigmented strains in clinical specimens. This does not exclude the possibility that other factors may further reduce the incidence of pigmented strains in clinical material (6, 9, 11) .
In conclusion, the O antigens of S. marcescens can be determined by dot EIA with greater accuracy than by agglutination. As correct identification of the O antigen improves the serological definition of strains, we recommend that reference laboratories evaluate this method for the routine typing of clinical isolates. With accurate determination of the LPS antigen, it should be possible to determine the prevalence of O antigens in different environments and to establish their relationship to other phenotypes, including potential virulence factors.
